Discover groundbreaking biomedical discoveries, pioneering health care innovations, and expert perspectives from Penn Medicine.
A first-of-its-kind clinical trial identified risk of breast cancer recurrence and successfully treated dormant tumor cells using existing drugs.
Public investments in biomedical research have an outsized effect, driving new scientific insights, economic growth, and ultimately treatments and cures.
Penn Medicine is joining a national collaboration to create the first comprehensive digital map of the healthy human body.
A young mother was diagnosed with a rare, deadly brain disorder. During her month-long coma, Penn Medicine’s bold care saved her life.
Tanner McIntosh was shocked to learn a brain tumor was causing his debilitating back pain. And then his surgeon suggested he be awake for its removal.
Every minute in the U.S., a woman needs a blood transfusion due to her period. Kathleen O’Neill, MD, is working to develop a novel therapy to protect women.
After her twin tested BRCA2-positive, Brooklyn Olumba got tested, leading to her own cancer diagnosis. Now she’s educating other young women of color.
A Lancaster General Health nurse’s selfless uterus donation transformed a woman’s dream of motherhood. Meet Sara, Emma, and baby Olivia in a story of science and generosity.
In Linda Ruggiero’s hands, the processes, tools, and challenges she encounters in health care—and in life—become art.
A global partnership between Doylestown Health’s Albert Ruenes, MD, and Senegal’s Serigne Gueye, MD, is transforming urologic care across West Africa.
A $50 million gift from the Lurie family to Children’s Hospital of Philadelphia and Penn Medicine will launch the Lurie Autism Institute to drive autism research.
In a historic medical breakthrough, a child with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy.
A reimagined facility has been introduced as the epicenter for pioneering Penn research aimed at “breaking the immunological code” of autoimmune diseases and bringing them to heel.
At the unveiling of a refurbished basketball court, Penn Medicine and the 76ers announced a $144,000 donation to grassroots organizations.
At Camp Erin, a grief camp supported by Penn Medicine Hospice, trained volunteers have helped a generation of campers mourn and remember loved ones.
In Lancaster County, ChildProtect community clinics have provided free vaccines against preventable diseases for 30 years—with an added dose of trust.
At Penn Medicine, health care is about the architecture of care for entire communities where people can access treatment when and where they need it.
While a student at Penn, David Fajgenbaum, MD, MBA, identified a drug already on the market that could help treat his disease. He’s now using AI to uncover new uses for already-approved FDA drugs. – September, 10, 2025
New clinical trial results from Nature Medicine revealed that existing drugs can successfully kill dormant breast cancer cells and cut someone’s lifetime risk of recurrence. – September, 10, 2025
Ramon Diaz-Arrastia, MD, PhD, director of Penn’s Traumatic Brain Injury Clinical Research Center, emphasized the need for larger, randomized controlled trials to show the drug ibogaine is effective and safe in treating brain injuries. – September 12, 2025
Subscribe to Penn Medicine newsletters and publications for the latest developments.
